Interferon-a potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment.
Cancer Discov. 2022 Apr 12:candisc.1022.2021. doi: 10.1158/2159-8290.CD-21-1022. Online ahead of print.
Cancer Discov. 2022.
PMID: 35412588